Werewolf Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.

CEO

Daniel J. Hicklin

CEODaniel J. Hicklin

Employees

Employees47

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2017

Founded2017

Employees

Employees47

HOWL Key Statistics

Market cap

84.45M

Market cap84.45M

Price-Earnings ratio

-1.27

Price-Earnings ratio-1.27

Dividend yield

—

Dividend yield—

Average volume

596.20K

Average volume596.20K

High today

$1.97

High today$1.97

Low today

$1.73

Low today$1.73

Open price

$1.83

Open price$1.83

Volume

644.83K

Volume644.83K

52 Week high

$8.19

52 Week high$8.19

52 Week low

$1.58

52 Week low$1.58

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Werewolf Therapeutics

Why Robinhood?

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. Show more

HOWL Key Statistics

Analyst ratings

100%

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.